Ftse Mib
34.374,77
0,55%
DAX
20.024,66
0,58%
S&P 500
5.868,55
-0,22%
NASDAQ
19.280,79
-0,16%
Bitcoin
96.908,61
0,01%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Abbott Laboratories (ABT) Abbott Laboratories (ABT) Notizie

ABT

Abbott Laboratories (ABT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ABT
DataOraFonteTitoloSimboloCompagnia
02/01/202515:00PR Newswire (US)Abbott Hosts Conference Call for Fourth-Quarter EarningsNYSE:ABTAbbott Laboratories
17/12/202422:03PR Newswire (Canada)Le système FreeStyle Libre 2® d'Abbott est maintenant remboursé pour les enfants et les adultes de l'Alberta vivant avec le diabèteNYSE:ABTAbbott Laboratories
17/12/202422:03PR Newswire (Canada)Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in AlbertaNYSE:ABTAbbott Laboratories
17/12/202413:00PR Newswire (US)Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the HeartNYSE:ABTAbbott Laboratories
13/12/202416:58PR Newswire (US)Abbott Increases Quarterly Dividend for 53rd Consecutive YearNYSE:ABTAbbott Laboratories
08/12/202403:14PR Newswire (US)University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from AbbottNYSE:ABTAbbott Laboratories
25/11/202413:00PR Newswire (US)Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic StenosisNYSE:ABTAbbott Laboratories
18/11/202412:00PR Newswire (US)Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, IrelandNYSE:ABTAbbott Laboratories
15/11/202422:13Edgar (US Regulatory)Form 8-K - Current reportNYSE:ABTAbbott Laboratories
04/11/202422:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
01/11/202411:57IH Market NewsIndex Futures Rise on Jobs Report and Chevron, Exxon Earnings Anticipation; Oil Prices SurgeNYSE:ABTAbbott Laboratories
01/11/202411:55IH Market NewsAmazon Up 6%, Atlassian Jumps 20%; Intel Posts Surprising Profit; Abbott Wins Infant Formula LawsuitNYSE:ABTAbbott Laboratories
31/10/202422:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ABTAbbott Laboratories
30/10/202415:08PR Newswire (Canada)Un nouveau rapport canadien montre qu'une attitude positive est préférable à la critique dans la prise en charge du diabèteNYSE:ABTAbbott Laboratories
30/10/202414:50PR Newswire (Canada)New Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes ManagementNYSE:ABTAbbott Laboratories
24/10/202415:00PR Newswire (US)Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart FailureNYSE:ABTAbbott Laboratories
23/10/202423:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
16/10/202413:30PR Newswire (US)Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance RangeNYSE:ABTAbbott Laboratories
10/10/202415:00PR Newswire (US)Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac MappingNYSE:ABTAbbott Laboratories
26/09/202420:00PR Newswire (US)Abbott and the Big Ten Conference Tackle U.S. Blood Shortages with First-of-its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'NYSE:ABTAbbott Laboratories
25/09/202415:00PR Newswire (US)Abbott Hosts Conference Call for Third-Quarter EarningsNYSE:ABTAbbott Laboratories
19/09/202418:59PR Newswire (US)Abbott Declares 403rd Consecutive Quarterly DividendNYSE:ABTAbbott Laboratories
05/09/202415:00PR Newswire (US)Abbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S.NYSE:ABTAbbott Laboratories
04/09/202415:00PR Newswire (US)Abbott Initiates Clinical Study to Evaluate the Use of Its Deep Brain Stimulation System to Manage Severe DepressionNYSE:ABTAbbott Laboratories
27/08/202415:00PR Newswire (US)Abbott Expands its Pure Bliss™ Line of Infant Formulas to Include European-Made and Organic Products; Offers the First and Only Organic Liquid Formula Available at U.S. Retail StoresNYSE:ABTAbbott Laboratories
15/08/202420:18PR Newswire (Canada)AVEIR(MC) DR d'Abbott - Le premier système de stimulateur cardiaque double chambre sans sonde est maintenant offert au CanadaNYSE:ABTAbbott Laboratories
15/08/202419:44PR Newswire (Canada)Abbott's AVEIR™ DR - World's First Dual Chamber Leadless Pacemaker System - Now Available in CanadaNYSE:ABTAbbott Laboratories
08/08/202415:00PR Newswire (Canada)Quebec Expands Public Reimbursement of Abbott's FreeStyle Libre® 2 Flash Glucose Monitoring System to More Adults with DiabetesNYSE:ABTAbbott Laboratories
08/08/202415:00PR Newswire (Canada)Québec élargit sa couverture publique du système flash de surveillance du glucose FreeStyle Libre 2 à un plus grand nombre d'adultes atteints de diabèteNYSE:ABTAbbott Laboratories
07/08/202414:00PR Newswire (US)Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery DevicesNYSE:ABTAbbott Laboratories
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ABT

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
IVG
Iveco Group NV
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
SRG
Snam
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network